This High-Growth, Under-the-Radar Stock Has 80% Upside, According to Wall Street
Cosmetic device company The Beauty Health Company (NASDAQ: SKIN) went public in May 2021 via a merger with a special purpose acquisition company (SPAC). Most SPAC stocks have been utter disasters, but this one is a rare exception, still trading above its initial $10 per share price.
I believe BeautyHealth checks important boxes for long-term investors -- and Wall Street generally agrees. According to TipRanks, all eight of the analysts following the stock rate it a buy, with an average price target of $22.63 per share -- more than 80% higher than where it trades now.
In 2005, BeautyHealth created a machine for performing cosmetic facial procedures using water for abrasion. This became its HydraFacial platform. The device itself has undergone several iterations, most recently with its Syndeo HydraFacial machine, which launched earlier this year.
Source Fool.com
